CompletedNCT03426865
Role of Axumin PET Scan in Germ Cell Tumor
Studying Tumor of testis and paratestis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Yair Lotan, MDUniversity of Texas Southwestern Medical Center
- Intervention
- Axumin PET scan(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2018 – 2023
Study locations (1)
- UT Southwestern Medical Center, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03426865 on ClinicalTrials.govOther trials for Tumor of testis and paratestis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06593665Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.Indiana University
- RECRUITINGPHASE2NCT06144736PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLNDHeinrich-Heine University, Duesseldorf
- RECRUITINGNCT05564026Molecular Epidemiology of Pediatric Germ Cell TumorsChildren's Oncology Group
- RECRUITINGPHASE2NCT05529251De-escalation Study for Stage IIa/IIb < 3 cm SeminomaCentre Leon Berard
- ACTIVE NOT RECRUITINGPHASE2NCT03937843Reduced Intensity Radio-chemotherapy for Stage IIA/B SeminomaSwiss Cancer Institute
- RECRUITINGNANCT04113122Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT StudyUniversity Medical Center Groningen
- ACTIVE NOT RECRUITINGPHASE2NCT03158064Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGNANCT01049230Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell TumorsMassachusetts General Hospital